Gross Profit: Revenues from operations less the associated costs.
BioLargo, Inc. (BLGO) had Gross Profit of $0.46M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.11M |
|
$-2.29M |
|
$0.66M |
|
|
Gross Profit |
$0.46M |
$4.32M |
|
$-3.20M |
|
$-0.20M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.20M |
|
$-3.03M |
|
318.70M |
|
318.70M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$5.45M |
|
$1.64M |
|
$3.12M |
|
$8.56M |
|
$4.93M |
|
$3.01M |
|
$3.82M |
|
$8.75M |
|
$-0.19M |
|
$-0.19M |
|
$-0.19M |
|
319.70M |
|
| Cash Flow Statement Financials | |
$-2.92M |
|
$-0.03M |
|
$3.19M |
|
$3.88M |
|
$4.12M |
|
$0.24M |
|
$0.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.10 |
|
-- |
|
-- |
|
1.07 |
|
-24.77 |
|
41.08% |
|
-287.35% |
|
-287.35% |
|
-- |
|
-305.38% |
|
-205.02% |
|
$-2.95M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
2.25 |
|
1.53 |
|
58.92 |
|
1820.96% |
|
1820.85% |
|
-39.75% |
|
-120.53% |
|
$-0.00 |
|
$-0.01 |
|
$-0.01 |
|